Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
IEEE Transactions on Medical Imaging|February 2, 2022
Radiomic Deformation and Textural Heterogeneity (R-DepTH) Descriptor to Characterize Tumor Field Effect: Application to Survival Prediction in GlioblastomaMarwa Ismail, Prateek Prasanna, Kaustav Bera, et al.Neuro-Oncology Advances|January 28, 2021
An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation statusManmeet Ahluwalia, Mir A Ali, Rushikesh S Joshi, et al.Scientific Reports|January 10, 2018
Radiogenomic analysis of hypoxia pathway is predictive of overall survival in GlioblastomaNiha Beig, Jay Patel, Prateek Prasanna, et al.World Neurosurgery|July 24, 2017
Cumulative Intracranial Tumor Volume and Number of Brain Metastasis as Predictors of Developing New Lesions After Stereotactic Radiosurgery for Brain MetastasisMayur Sharma, Xuefei Jia, Manmeet Ahluwalia, et al.Cancer Medicine|August 5, 2017
First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastasesMayur Sharma, Xuefei Jia, Manmeet Ahluwalia, et al.Lancet Regional Health. Americas|September 11, 2025
A nomogram to predict development of brain metastasis in non-small cell lung cancer patients: a retrospective analysis using routinely available medical recordsHannah Wilding, Nicholas Mikolajewicz, Debarati Bhanja, et al.Journal of Neurosurgery|May 5, 2018
Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosisManmeet Ahluwalia, Gene H Barnett, Di Deng, et al.Journal of Neuro-Oncology|October 21, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastomaRoy Strowd, Benjamin Ellingson, Catalina Raymond, et al.Neuro-Oncology Advances|December 23, 2024
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade gliomaCrismita Dmello, Andrew Brenner, David Piccioni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2025
A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent ImmunotherapyDebarati Bhanja, Junjia Zhu, Hannah Wilding, et al.Pageof 4